Medical News

Microbiota Thrombus Colonization may influence AtheRo-thromb...
Diabetes Res Clin Pract.

Hyperglycemia during STEMI may increase coronary thrombus burden via gut and thrombus microbiota dysbiosis...

15 Jan 2021

Cardiovascular Dysfunction in Children Exposed to Preeclamps...
J Am Soc Echocardiogr.

In-utero exposure to preeclampsia has an effect on the vascular function in children aged 2-10 years, primarily...

15 Jan 2021

Primary Percutaneous Coronary Intervention in Nonagenarians:...
BMC Cardiovasc Disord.

In this series of selected nonagenarians presenting with acute myocardial infarction, those undergoing PPCI...

15 Jan 2021

Triglyceride–Glucose Index is associated with the Risk of My...
Cardiovasc Diabetol.

Elevated levels of the baseline and long-term TyG index are associated with an increased risk of MI. This finding...

14 Jan 2021

Key Trials

PIONEER-HF: Efficacy and Safety of Sacubitril/Valsartan in ADHF Patients as per the Dose Level Achieved

Sacubitril/valsartan exhibited generally consistent efficacy and safety across various dose levels in hemodynamically stabilized patients with ADHF...

Loop Diuretic Dose Change and the Outcomes in Chronic HF Patients: Insights from the ESC-EORP HF Long-Term Registry

This large-scale study demonstrated very low rate of loop diuretic (LD) dose down-titration in chronic HF patients, depicting the high discordance...

Impact of Sacubitril/Valsartan on Sudden Cardiac Death as per ICD Use and HF Cause

This sub-group analysis of the PARADIGM HF study demonstrates under-usage of ICD in patients with HFrEF despite reduction in sudden cardiac death....

PIONEER HF: Sacubitril/valsartan in African-American Patients with ADHF

This subgroup analysis of the PIONEER-HF trial demonstrated sacubitril/valsartan to be equally effective and safe in African-American and non-...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

 
Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page

Our Publications

Rivazest (Rivaroxaban) Monograph

Rivaroxaban is a potent, selective, orally active direct inhibitor of the activated serine protease Factor X (FXa), which plays a central role in...

Telyse (Tenecteplase) Monograph

In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....

Mexiletine FAQ Booklet

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
26% (6 votes)
20-40%
22% (5 votes)
40-50%
13% (3 votes)
50-70%
13% (3 votes)
70-80%
22% (5 votes)
Almost all
4% (1 vote)
Total votes: 23